AstraZeneca PLC
AZN
$77.85
-$0.1095-0.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.53B | 4.93B | 7.08B | 8.02B | 5.86B |
| Total Receivables | 13.09B | 13.55B | 12.62B | 12.23B | 11.94B |
| Inventory | 5.29B | 5.66B | 5.67B | 5.34B | 5.42B |
| Prepaid Expenses | 1.74B | -- | -- | -- | 1.62B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 183.00M | 16.00M | 28.00M | 11.00M | 218.00M |
| Total Current Assets | 25.83B | 24.16B | 25.39B | 25.59B | 25.05B |
|
|
|||||
| Total Current Assets | 25.83B | 24.16B | 25.39B | 25.59B | 25.05B |
| Net Property, Plant & Equipment | 11.65B | 11.51B | 10.83B | 10.62B | 10.50B |
| Long-term Investments | 21.03B | 21.14B | 21.06B | 19.98B | 20.05B |
| Goodwill | 21.03B | 21.14B | 21.06B | 19.98B | 20.05B |
| Total Other Intangibles | 37.18B | 39.39B | 39.43B | 38.83B | 38.09B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.46B | 6.58B | 5.76B | 5.58B | 5.75B |
| Total Assets | 104.04B | 104.92B | 104.34B | 102.29B | 101.12B |
|
|
|||||
| Total Accounts Payable | 3.64B | 21.68B | 20.46B | 19.70B | 3.27B |
| Total Accrued Expenses | 16.09B | -- | -- | -- | 15.85B |
| Short-term Debt | 2.34B | 1.24B | 3.05B | 1.46B | 5.13B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 389.00M | 346.00M | 2.36B | 4.97B | 1.26B |
| Total Finance Division Other Current Liabilities | 5.41B | 2.66B | 2.69B | 2.78B | 5.04B |
| Total Other Current Liabilities | 5.41B | 2.66B | 2.69B | 2.78B | 5.04B |
| Total Current Liabilities | 27.87B | 25.93B | 28.57B | 28.90B | 30.54B |
|
|
|||||
| Total Current Liabilities | 27.87B | 25.93B | 28.57B | 28.90B | 30.54B |
| Long-Term Debt | 26.62B | 28.92B | 27.29B | 27.31B | 22.40B |
| Short-term Debt | 2.34B | 1.24B | 3.05B | 1.46B | 5.13B |
| Capital Leases | 1.11B | 1.11B | 949.00M | 961.00M | 857.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.56B | 8.17B | 7.94B | 7.62B | 8.15B |
| Total Liabilities | 63.16B | 64.12B | 64.74B | 64.79B | 61.95B |
|
|
|||||
| Common Stock & APIC | 35.61B | 35.59B | 35.59B | 35.58B | 35.58B |
| Retained Earnings | 7.23B | 3.14B | 1.85B | -212.00M | 4.52B |
| Treasury Stock & Other | -2.06B | 1.99B | 2.08B | 2.08B | -949.00M |
| Total Common Equity | 40.79B | 40.72B | 39.51B | 37.45B | 39.14B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 40.79B | 40.72B | 39.51B | 37.45B | 39.14B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 85.00M | 86.00M | 86.00M | 56.00M | 23.00M |
| Total Equity | 40.87B | 40.81B | 39.60B | 37.50B | 39.17B |
|
|
|||||
